Clinical Trials Directory

Trials / Completed

CompletedNCT04982822

Novel Senhance Robotic System in Urologic Surgery: Its Clinical Application and Implication

Status
Completed
Phase
Study type
Observational
Enrollment
314 (actual)
Sponsor
National Taiwan University Hospital · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Accepted

Summary

An observational study to collect data from the participants who received urologic surgeries using the Senhance Robotic system.

Detailed description

This is an observational study and investigators will collect peri-operative demographic data, and short-term outcomes (3-6 months) from the participants who received minimal invasive surgeries using Senhance robotic system in the National Taiwan University Hospital Yunlin Branch, Urology Department. The investigators want to demonstrate if the robotic system is safe and feasible in urologic laparoscopic surgeries. The operation included TEP, radical prostatectomy, radical nephrectomy (nephroureterectomy) , adrenalectomy, radical cystectomy, and ureter surgery et al. up to 2022/12, we had recruited 127 TEP, 83 radical prostatectomies, 17 adrenalectomies, 40 nephrectomies, 29 partial nephrectomies, 13 radical cystectomies and 18 other surgeries, such as ureter surgery

Conditions

Timeline

Start date
2020-12-01
Primary completion
2022-12-31
Completion
2024-01-31
First posted
2021-07-29
Last updated
2024-06-25

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT04982822. Inclusion in this directory is not an endorsement.

Novel Senhance Robotic System in Urologic Surgery: Its Clinical Application and Implication (NCT04982822) · Clinical Trials Directory